Helen H Hobbs MD
Clinical Molecular Genetics
Professor of Medicine, University Tex SW Dallas
Join to View Full Profile
5323 Harry Hines BlvdDallas, TX 75390
Phone+1 214-645-2868
Fax+1 214-648-1666
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Helen Hobbs, MD is a medical geneticist in Dallas, Texas. She is currently licensed to practice medicine in Texas. She is a Professor of Medicine at University Tex SW Dallas.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1986- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1980 - 1983
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1979 - 1980
Case Western Reserve University School of MedicineClass of 1979
Certifications & Licensure
TX State Medical License 1982 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Publications & Presentations
PubMed
- 25 citationsPNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis.Yang Wang, Sen Hong, Hannah Hudson, Nora Kory, Lisa N Kinch
Journal of Hepatology. 2025-05-01 - 8 citationsThe ubiquitin E3 ligase BFAR promotes degradation of PNPLA3.Avash Das, Haili Cheng, Yang Wang, Lisa N Kinch, Guosheng Liang
Proceedings of the National Academy of Sciences of the United States of America. 2024-02-06 - 7 citationsPCSK9: From Nature's Loss to Patient's Gain.Helen H Hobbs, Jonathan C Cohen, Jay D Horton
Circulation. 2024-01-16
Press Mentions
At 25, the Dallas Heart Study Is Shaping Cardiac Care and Exploring Links to Brain HealthAugust 25th, 2025- A Powerhouse of Obesity Research – Then and NowSeptember 20th, 2024
- Bringing Together Science and the Lived Experience at Family Heart Global SummitAugust 21st, 2024
Grant Support
- PNPLA3 in Susceptibility and Resistance to Fatty Liver DiseaseUT SOUTHWESTERN MEDICAL CENTER2011–2027
- Role of ABCG1, ABCG5 and ABCG8 in Sterol MetabolismUT SOUTHWESTERN MEDICAL CENTER2003–2025
